Patent & IP news for July 17, 2017
Patent Litigations
- No new litigations this day!
USPTO Weekly Stats
5,967
published
appl'ns
appl'ns
7,371
granted
patents
patents
64
ptab
decisions
decisions
Patent & IP Blogs
Who actually recorded "He's a Rebel"? from ipbiz.blogspot.com If you listen to '60s radio, you are likely to hear "He's a Rebel," which you will be told was recorded by
the Crystals.
But, although that is what the record says, it isn ...
MILLENNIUM PHARMACEUTICALS scores win at CAFC in '446 (Velcade® ) case; Judge Newman explicates obviousness from ipbiz.blogspot.com The case pertains to the chemical compound D-mannitol
N-(2-pyrazine)carbonyl-L-phenylalanine-Lleucine
boronate, described in the text
The mannitol
ester of bortezomib acts as a “prodrug,” a compound that
converts to or releases the active pharmaceutical ...
Sky v SkyKick - no CJEU reference re removal of own name defence to EUTMs from ipkitten.blogspot.com
Is Article 1(13) of Regulation 2015/2424 contrary to fundamental rights? This is a question that SkyKick recently sought to refer to the Court of Justice of the European Union (CJEU) in Sky v ...
Is Article 1(13) of Regulation 2015/2424 contrary to fundamental rights? This is a question that SkyKick recently sought to refer to the Court of Justice of the European Union (CJEU) in Sky v ...
Computer Modeling and Electrical System Simulation Patents Invalid Under 35 U.S.C. § 101 from docketreport.blogspot.com
The court granted defendant's motion for summary judgment on invalidity because the asserted claims of plaintiff’s computer modeling and electrical system simulation patents encompassed unpatentable subject matter and found that the claims were ...
The court granted defendant's motion for summary judgment on invalidity because the asserted claims of plaintiff’s computer modeling and electrical system simulation patents encompassed unpatentable subject matter and found that the claims were ...
Temporary Compulsory License For Antiretroviral Drug Upheld By German Court from www.ip-watch.org
MUNICH -- The German Federal Supreme Court in a decision drawing significant attention on 11 July upheld a temporary compulsory licence granted for the HIV drug Isentress (X ZB 2/17). The antiretroviral drug, based on ...
MUNICH -- The German Federal Supreme Court in a decision drawing significant attention on 11 July upheld a temporary compulsory licence granted for the HIV drug Isentress (X ZB 2/17). The antiretroviral drug, based on ...
Qualcomm counter-offensive reminds NY Times readers who put the ‘smart’ in smartphone from ipcloseup.com
Qualcomm is the first known patent licensor to tout its invention prowess in a New York Times ad directed at the business community. One of the world’s most successful licensing businesses reminded Times readers ...
Qualcomm is the first known patent licensor to tout its invention prowess in a New York Times ad directed at the business community. One of the world’s most successful licensing businesses reminded Times readers ...
WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 from www.ip-watch.org
A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors.
A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors.
When is an the inherent, but unexpected result obvious? from patentlyo.com
Millennium Pharma v. Sandoz (Federal Circuit 2017) As part of a brand-generic pharma battle, the district court invalidated a set of Millennium’s patent claims covering its Velcade drug used to treat multiple myeloma.[1 ...
Millennium Pharma v. Sandoz (Federal Circuit 2017) As part of a brand-generic pharma battle, the district court invalidated a set of Millennium’s patent claims covering its Velcade drug used to treat multiple myeloma.[1 ...
An improved Improver? - Part 2 from ipkitten.blogspot.com
Here as promised is the second part of this GuestKat's commentary on Eli Lilly v Actavis UK [2017] UKSC 48, which promises to have much ink spilled and air of various temperatures emitted on ...
Here as promised is the second part of this GuestKat's commentary on Eli Lilly v Actavis UK [2017] UKSC 48, which promises to have much ink spilled and air of various temperatures emitted on ...
Oral Argument of the Day from www.717madisonplace.com
The oral argument of the day is from INTEGRATED CLAIMS SYSTEMS, LLC v. TRAVELERS LLOYDS OF TEXAS INSURANCE COMPANY, No. 2016-2163 (Fed. Cir. Apr. 11, 2017). The oral argument primarily concerns application of the court ...
The oral argument of the day is from INTEGRATED CLAIMS SYSTEMS, LLC v. TRAVELERS LLOYDS OF TEXAS INSURANCE COMPANY, No. 2016-2163 (Fed. Cir. Apr. 11, 2017). The oral argument primarily concerns application of the court ...
Some content © 2007–2017 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.
Terms of Service & Privacy Policy
For DMCA requests contact help@priorsmart.com.